Moderna’s mRNA COVID-19 vaccine candidate has 94.5% efficacy EMA starts rolling review, company to submit for USFDA EUA in coming weeks
Will a COVID 19 vaccine truly be a game-changer? Dhanashree Bapat (Assistant Manager, Pharma) Business Research & Advisory, Aranca writes on how will a COVID–19 vaccine impact…
